Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
Go back to Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026| EVOGENE LTD. (NASDAQ: EVGN) | Delayed: 0.39 -0.05 (11.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.44 | 52 Week High | $9.32 | |||
| Open | $0.42 | 52 Week Low | $5.79 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $0.00 | |||
| Volume | 860,435 | |||||
| EVOGENE LTD. (NASDAQ: EVGN) | Delayed: 0.39 -0.05 (11.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.44 | 52 Week High | $9.32 | |||
| Open | $0.42 | 52 Week Low | $5.79 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $0.00 | |||
| Volume | 860,435 | |||||

